Sara Hurvitz, a Professor of Medicine, is a medical oncologist and clinical research leader at the University of Washington School of Medicine, where she serves as Division Head of Hematology/Oncology, and at the Fred Hutchinson Cancer Center, where she serves as Senior Vice President of the Clinical Research Division. Dr. Hurvitz earned her MD from the University of Southern California. She served an internship/residency at UCLA, was Chief Resident of internal medicine, and completed a hematology-oncology fellowship at UCLA in 2006. Dr. Hurvitz received board certification in internal medicine, hematology, and medical oncology. As an international expert in breast oncology and a leader in clinical and laboratory-based oncology research, with extensive experience leading clinical trials in all phases, Dr. Hurvitz led the breast cancer clinical trials program at UCLA for 17 years and was Medical Director of the Jonsson Comprehensive Cancer Center until 2023 when she accepted a leadership position at UW/FHCC. Dr. Hurvitz has won numerous awards, among them the Marni Levine Memorial Breast Cancer Research Award 2008 through 2015 and the European Society of Medical Oncology Breast Cancer Award in 2023. She has an active clinical practice specializing in the treatment of women with breast cancer and continues to be involved in designing, implementing, and leading multiple national and international clinical trials testing new targeted therapies.